199 related articles for article (PubMed ID: 35466937)
21. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
22. Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans.
Reddy JS; Jin J; Lincoln SJ; Ho CCG; Crook JE; Wang X; Malphrus KG; Nguyen T; Tamvaka N; Greig-Custo MT; Lucas JA; Graff-Radford NR; Ertekin-Taner N; Carrasquillo MM
EBioMedicine; 2022 Apr; 78():103929. PubMed ID: 35307406
[TBL] [Abstract][Full Text] [Related]
23. Fundamental causes of barriers to participation in Alzheimer's clinical research among African Americans.
Lincoln KD; Chow T; Gaines BF; Fitzgerald T
Ethn Health; 2021 May; 26(4):585-599. PubMed ID: 30375237
[No Abstract] [Full Text] [Related]
24. Barriers and facilitators of African American participation in Alzheimer disease biomarker research.
Williams MM; Scharff DP; Mathews KJ; Hoffsuemmer JS; Jackson P; Morris JC; Edwards DF
Alzheimer Dis Assoc Disord; 2010; 24 Suppl(Suppl):S24-9. PubMed ID: 20711059
[TBL] [Abstract][Full Text] [Related]
25. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?
Cox CG; Ryan MM; Gillen DL; Grill JD
J Prev Alzheimers Dis; 2021; 8(1):52-58. PubMed ID: 33336225
[TBL] [Abstract][Full Text] [Related]
26. Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
Long JM; Coble DW; Xiong C; Schindler SE; Perrin RJ; Gordon BA; Benzinger TLS; Grant E; Fagan AM; Harari O; Cruchaga C; Holtzman DM; Morris JC
Brain; 2022 Dec; 145(12):4506-4518. PubMed ID: 35867858
[TBL] [Abstract][Full Text] [Related]
27. Qualitative Evaluation Informs Understanding of Motor Cognition and Therapies in Older Adults with Mild Cognitive Impairment.
Lazris D; Perkins MM; Bay AA; Hackney ME
J Alzheimers Dis; 2021; 84(2):691-703. PubMed ID: 34569954
[TBL] [Abstract][Full Text] [Related]
28. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
[TBL] [Abstract][Full Text] [Related]
29. Experiences of and recommendations on clinical trial design in Alzheimer's disease from the participant's point of view: a mixed-methods study in two clinical trial centers in the Netherlands.
Ottenhoff L; Vijverberg EGB; Visser LNC; Verijp M; Prins ND; Van der Flier WM; Sikkes SAM
Alzheimers Res Ther; 2023 Apr; 15(1):72. PubMed ID: 37016435
[TBL] [Abstract][Full Text] [Related]
30. Empirically derived psychosocial-behavioral phenotypes in Black/African American and Hispanic/Latino older adults enrolled in HABS-HD: Associations with AD biomarkers and cognitive outcomes.
Clark AL; Thomas KR; Ortega N; Haley AP; Duarte A; O'Bryant S;
Alzheimers Dement; 2024 Feb; 20(2):1360-1373. PubMed ID: 37990803
[TBL] [Abstract][Full Text] [Related]
31. Application of Digital Cognitive Biomarkers for Alzheimer's Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline.
Bock JR; Hara J; Fortier D; Lee MD; Petersen RC; Shankle WR
J Prev Alzheimers Dis; 2021; 8(2):123-126. PubMed ID: 33569557
[TBL] [Abstract][Full Text] [Related]
32. Knowledge and Attitudes in Alzheimer's Disease in a Cohort of Older African Americans and Caucasians.
Howell JC; Soyinka O; Parker M; Jarrett TL; Roberts DL; Dorbin CD; Hu WT
Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):361-7. PubMed ID: 26646115
[TBL] [Abstract][Full Text] [Related]
33. Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression.
Wisch JK; Butt OH; Gordon BA; Schindler SE; Fagan AM; Henson RL; Yang C; Boerwinkle AH; Benzinger TLS; Holtzman DM; Morris JC; Cruchaga C; Ances BM
Brain; 2023 Jul; 146(7):2944-2956. PubMed ID: 36542469
[TBL] [Abstract][Full Text] [Related]
34. Race modifies default mode connectivity in Alzheimer's disease.
Misiura MB; Howell JC; Wu J; Qiu D; Parker MW; Turner JA; Hu WT
Transl Neurodegener; 2020; 9():8. PubMed ID: 32099645
[TBL] [Abstract][Full Text] [Related]
35. Development and pilot implementation of guidelines for culturally tailored research recruitment materials for African Americans and Latinos.
Cunningham-Erves J; Kusnoor SV; Villalta-Gil V; Stallings SC; Ichimura JS; Israel TL; Harris PA; Wilkins CH
BMC Med Res Methodol; 2022 Sep; 22(1):248. PubMed ID: 36153481
[TBL] [Abstract][Full Text] [Related]
36. The Role of Transportation in the Enrollment of Elderly African Americans into Exercise and Memory Study: GEMS Study.
Graham L; Ngwa J; Ntekim O; Ogunlana O; Johnson S; Nadarajah S; Fungwe TV; Turner J; Ruiz MR; Khan J; Obisesan TO
J Racial Ethn Health Disparities; 2023 Aug; 10(4):1837-1845. PubMed ID: 35931916
[TBL] [Abstract][Full Text] [Related]
37. African American participation in Alzheimer's disease research that includes brain donation.
Darnell KR; McGuire C; Danner DD
Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):469-76. PubMed ID: 22009227
[TBL] [Abstract][Full Text] [Related]
38. Baseline Results: The Association Between Cardiovascular Risk and Preclinical Alzheimer's Disease Pathology (ASCEND) Study.
Kumar VV; Huang H; Zhao L; Verble DD; Nutaitis A; Tharwani SD; Brown AL; Zetterberg H; Hu W; Shin R; Kehoe PG; Quyyumi A; Nocera J; Kippels A; Wharton W
J Alzheimers Dis; 2020; 75(1):109-117. PubMed ID: 32280088
[TBL] [Abstract][Full Text] [Related]
39. Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's disease.
Akinleye I; Roberts JS; Royal CD; Linnenbringer E; Obisesan TO; Fasaye GA; Green RC
J Genet Couns; 2011 Dec; 20(6):650-9. PubMed ID: 21656311
[TBL] [Abstract][Full Text] [Related]
40. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
Alty J; Bai Q; Li R; Lawler K; St George RJ; Hill E; Bindoff A; Garg S; Wang X; Huang G; Zhang K; Rudd KD; Bartlett L; Goldberg LR; Collins JM; Hinder MR; Naismith SL; Hogg DC; King AE; Vickers JC
BMC Neurol; 2022 Jul; 22(1):266. PubMed ID: 35850660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
